Tillotts Pharma, a subsidary to the Swiss company Tillotts Pharma, starts under private management in Stockholm. The company is focused on gastroenterology and stand behind the drug Asacol, used against intestine inflammations. The drug’s turnover in the Nordic countries is almost SEK 170 million. The new Nordic Tillotts Pharma will continue to focus on Asacol.
